Aminolevulinic acid - SonALAsense
Alternative Names: 5-ALA - SonALAsense; 5-Aminolevulinic acid - SonALAsense; SONALA-001Latest Information Update: 28 Jul 2025
At a glance
- Originator SonALAsense
- Class Amino acids; Antianaemics; Antineoplastics; Diagnostic agents; Imaging agents; Keto acids; Levulinic acids; Nootropics; Skin disorder therapies; Small molecules; Vascular disorder therapies
- Mechanism of Action Photosensitisers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase II Glioblastoma
- Suspended Glioma
Most Recent Events
- 28 Jul 2025 SonALAsense in collaboration with Mayo clinic plans a phase Ib trial in Glioblastoma (Recurrent) in USA (IV, Infusion) (NCT07076472)
- 28 Jan 2025 No recent reports of development identified for preclinical development in Cancer in USA
- 16 Jan 2025 Chemical structure information added.